ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO0960

Epigenetic Analysis of Kidney Tissue to Elucidate the Pathophysiology of CKD Associated with Preterm Birth and Low Birth Weight

Session Information

Category: Pediatric Nephrology

  • 1800 Pediatric Nephrology

Authors

  • Ishimori, Shingo, Kobe University Graduate School of Medicine, Kobe, Japan
  • Fujimura, Junya, Kakogawa Chuo Shimin Byoin, Kakogawa, Hyogo Prefecture, Japan
  • Ishiko, Shinya, Takatsuki Byoin, Takatsuki, Osaka Prefecture, Japan
  • Nishimura, Ryo, Kobe University Graduate School of Medicine, Kobe, Japan
  • Baba, Minato, Kobe University Graduate School of Medicine, Kobe, Japan
  • Fujiwara, Ayako, Kobe University Graduate School of Medicine, Kobe, Japan
  • Yamamoto, Asahi, Kobe University Graduate School of Medicine, Kobe, Japan
  • Kimura, Yuka, Kobe University Graduate School of Medicine, Kobe, Japan
  • Aoyama, Shuhei, Kobe University Graduate School of Medicine, Kobe, Japan
  • Ichikawa, Yuta, Kobe University Graduate School of Medicine, Kobe, Japan
  • Inoki, Yuta, Kobe University Graduate School of Medicine, Kobe, Japan
  • Horinouchi, Tomoko, Kobe University Graduate School of Medicine, Kobe, Japan
  • Yamamura, Tomohiko, Kobe University Graduate School of Medicine, Kobe, Japan
  • Sakakibara, Nana, Kobe University Graduate School of Medicine, Kobe, Japan
  • Nagano, China, Kobe University Graduate School of Medicine, Kobe, Japan
  • Nozu, Kandai, Kobe University Graduate School of Medicine, Kobe, Japan
Background

Preterm birth (PB) and low birth weight (LBW) are established risk factors for chronic kidney disease (CKD), primarily through nephron underdevelopment, which is thought to drive tubulointerstitial fibrosis. Postnatal epigenetic alterations could contribute to the progression of PB- and LBW-associated CKD; however, these mechanisms have not yet been evaluated.

Methods

We conducted an epigenome-wide association study using genomic DNA (gDNA) extracted from 16 kidney biopsy specimens (8 cases of PB- and LBW-associated CKD and 8 controls). DNA methylation across more than 900,000 CpG sites was analyzed.

Results

Only two DMRs showing hypermethylation with a Δβ value > 0.05 were detected at a false discovery rate < 0.05: OSBPL8, which encodes a protein involved in lipid transport and intermembrane lipid exchange, and SHISA5, which encodes a protein that mediates endoplasmic reticulum (ER) stress responses and apoptosis (Fig. 1). The DMR in OSBPL8 was located within intron 1 and was annotated as an enhancer-like signature, whereas the DMR in SHISA5 was located in the promoter region 1–2 kb upstream of the transcription start site. In epigenetic clock analysis using gDNA derived from kidney specimens, an earlier gestational age was significantly associated with increased HorvathAge estimator acceleration (Fig. 2). p16INK4a immunostaining for the evaluation of cellular senescence was predominantly detected in the distal tubules of children with PB- and LBW-associated CKD (Fig. 3).

Conclusion

Hypermethylation of the enhancer-like signature in OSBPL8 may lead to impaired intracellular lipid transport and lipotoxicity, whereas hypermethylation of the promoter region in SHISA5 may result in decreased tolerance to ER stress. Consequently, PB and LBW may predispose the kidney to functional impairment by rendering tubular cells vulnerable to chronic stress through epigenetically mediated processes that promote aging and cellular senescence.